Articles with "doses chadox1" as a keyword



Photo by tirzavandijk from unsplash

Two flares of Still’s disease after two doses of the ChAdOx1 vaccine

Sign Up to like & get
recommendations!
Published in 2022 at "Clinical Rheumatology"

DOI: 10.1007/s10067-022-06124-z

Abstract: We report the case of an 18-year-old male with Still’s disease for the last 3 years, in remission, who developed two flares of his disease after receiving two doses of the ChAdOX1 nCoV-19 vaccine. While… read more here.

Keywords: two doses; flares still; doses chadox1; vaccine ... See more keywords
Photo from wikipedia

Waning of first- and second-dose ChAdOx1 and BNT162b2 COVID-19 vaccinations: a pooled target trial study of 12.9 million individuals in England, Northern Ireland, Scotland and Wales

Sign Up to like & get
recommendations!
Published in 2022 at "International Journal of Epidemiology"

DOI: 10.1093/ije/dyac199

Abstract: Abstract Background Several SARS-CoV-2 vaccines have been shown to provide protection against COVID-19 hospitalization and death. However, some evidence suggests that notable waning in effectiveness against these outcomes occurs within months of vaccination. We undertook… read more here.

Keywords: first second; bnt162b2; covid; target trial ... See more keywords
Photo from wikipedia

Immunogenicity of Third-dose BNT162b2 mRNA Vaccine Following Two Doses of ChAdOx1 in Health Care Workers: A Prospective Longitudinal Study

Sign Up to like & get
recommendations!
Published in 2022 at "Annals of Laboratory Medicine"

DOI: 10.3343/alm.2022.42.6.688

Abstract: Following the original severe acute respiratory syndrome coronavirus 2 strain (Wuhan-Hu-1) in December 2019, the Delta variant in May 2021 and the Omicron variant in December 2021 were classified as variants of concern. The pandemic… read more here.

Keywords: immunogenicity third; doses chadox1; bnt162b2; third dose ... See more keywords
Photo from wikipedia

Antibody Response Induced by Two Doses of ChAdOx1 nCoV-19, mRNA-1273, or BNT162b2 in Liver Transplant Recipients

Sign Up to like & get
recommendations!
Published in 2022 at "Immune Network"

DOI: 10.4110/in.2022.22.e24

Abstract: Coronavirus disease 2019 (COVID-19) vaccination in immunocompromised, especially transplant recipients, may induce a weaker immune response. But there are limited data on the immune response after COVID-19 vaccination in liver transplant (LT) recipients, especially on… read more here.

Keywords: response; mrna 1273; two doses; vaccine ... See more keywords